ASX:IRX

Inhalerx Stock Forecast, Price & News

Add

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Receive IRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Inhalerx and its competitors with MarketBeat's FREE daily newsletter.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: ASX:IRX
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $22.48 thousand
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.02 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.16
Quick Ratio: 6.93

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.33 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Inhalerx.

0.0 Community Rank

Outperform Votes
Inhalerx has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Inhalerx has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Inhalerx and other stocks. Vote “Outperform” if you believe IRX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Inhalerx does not currently pay a dividend.
Dividend Growth
Inhalerx does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inhalerx insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$32,051.00 in company stock and sold A$0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Inhalerx (ASX:IRX) Frequently Asked Questions

What is Inhalerx's stock symbol?: Inhalerx trades on the ASX under the ticker symbol "IRX."
How much money does Inhalerx make?: Inhalerx has a market capitalization of $0.00 and generates $22.48 thousand in revenue each year.

This page was last updated on 11/29/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.